YAP1 takes over when oncogenic K-Ras slumbers
- PMID: 24995973
- DOI: 10.1016/j.cell.2014.06.021
YAP1 takes over when oncogenic K-Ras slumbers
Abstract
It is of great therapeutic importance to understand why tumors relapse after the failure of therapies targeting oncogenes to which cancer cells are addicted. In this issue, Kapoor et al. and Shao et al. identify the transcriptional coactivator YAP1 as a central driver of compensation for the loss of K-Ras signaling in K-Ras-dependent cancers.
Copyright © 2014 Elsevier Inc. All rights reserved.
Comment on
-
Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.Cell. 2014 Jul 3;158(1):185-197. doi: 10.1016/j.cell.2014.06.003. Epub 2014 Jun 19. Cell. 2014. PMID: 24954535 Free PMC article.
-
KRAS and YAP1 converge to regulate EMT and tumor survival.Cell. 2014 Jul 3;158(1):171-84. doi: 10.1016/j.cell.2014.06.004. Epub 2014 Jun 19. Cell. 2014. PMID: 24954536 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
